• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID and the Renin-Angiotensin System: Are Hypertension or Its Treatments Deleterious?

作者信息

Zores Florian, Rebeaud Mathieu E

机构信息

Groupe Médical Spécialisé, Strasbourg, France.

DBMV, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

出版信息

Front Cardiovasc Med. 2020 Apr 23;7:71. doi: 10.3389/fcvm.2020.00071. eCollection 2020.

DOI:10.3389/fcvm.2020.00071
PMID:32391384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7191060/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b69c/7191060/3cad405b55a5/fcvm-07-00071-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b69c/7191060/3cad405b55a5/fcvm-07-00071-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b69c/7191060/3cad405b55a5/fcvm-07-00071-g0001.jpg

相似文献

1
COVID and the Renin-Angiotensin System: Are Hypertension or Its Treatments Deleterious?新冠病毒与肾素-血管紧张素系统：高血压或其治疗方法有害吗？
Front Cardiovasc Med. 2020 Apr 23;7:71. doi: 10.3389/fcvm.2020.00071. eCollection 2020.
2
DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?糖尿病与新冠病毒肺炎中的二肽基肽酶4和血管紧张素转换酶2：心血管并发症的治疗靶点？
Front Pharmacol. 2020 Aug 7;11:1161. doi: 10.3389/fphar.2020.01161. eCollection 2020.
3
Role of the Backbenchers of the Renin-Angiotensin System ACE2 and AT2 Receptors in COVID-19: Lessons From SARS.肾素-血管紧张素系统的ACE2和AT2受体的后座议员在COVID-19中的作用：来自SARS的教训。 （注：这里的“Backbenchers”翻译可能不太准确，原词在医学语境下可能有特定含义，需结合更专业背景理解，仅按字面翻译为“后座议员” 。整体译文仅供参考，具体需根据上下文和专业知识进一步优化。）
Cureus. 2020 Jun 2;12(6):e8411. doi: 10.7759/cureus.8411.
4
Effects of Renin-Angiotensin Inhibition on ACE2 and TMPRSS2 Expression: Insights into COVID-19.肾素-血管紧张素抑制对ACE2和TMPRSS2表达的影响：对COVID-19的见解
bioRxiv. 2020 Jun 18:2020.06.08.137331. doi: 10.1101/2020.06.08.137331.
5
Combination Therapy Using Inhalable GapmeR and Recombinant ACE2 for COVID-19.吸入式GapmeR与重组血管紧张素转换酶2联合治疗新型冠状病毒肺炎
Front Mol Biosci. 2020 Aug 7;7:197. doi: 10.3389/fmolb.2020.00197. eCollection 2020.
6
[Are renin-angiotensin system inhibitors protective or deleterious in patients with COVID-19?].[肾素-血管紧张素系统抑制剂对新型冠状病毒肺炎患者是保护性的还是有害的？]
Arch Mal Coeur Vaiss Pratique. 2020 Oct;2020(291):20-24. doi: 10.1016/j.amcp.2020.07.004. Epub 2020 Jul 17.

引用本文的文献

1
Association of COVID-19 with Comorbidities: An Update.新型冠状病毒肺炎与合并症的关联：最新进展
ACS Pharmacol Transl Sci. 2023 Feb 27;6(3):334-354. doi: 10.1021/acsptsci.2c00181. eCollection 2023 Mar 10.
2
Association of ACE2 Gene Variants with the Severity of COVID-19 Disease-A Prospective Observational Study.ACE2 基因变异与 COVID-19 疾病严重程度的关联：一项前瞻性观察研究。
Int J Environ Res Public Health. 2022 Oct 2;19(19):12622. doi: 10.3390/ijerph191912622.
3
Curcumin to inhibit binding of spike glycoprotein to ACE2 receptors: computational modelling, simulations, and ADMET studies to explore curcuminoids against novel SARS-CoV-2 targets.

本文引用的文献

1
High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation.严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）需要有创机械通气患者中肥胖的高患病率。
Obesity (Silver Spring). 2020 Jul;28(7):1195-1199. doi: 10.1002/oby.22831. Epub 2020 Jun 10.
2
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
3
The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2.
姜黄素抑制刺突糖蛋白与ACE2受体的结合：计算建模、模拟以及药物代谢和毒性研究以探索姜黄素类化合物针对新型SARS-CoV-2靶点的作用
RSC Adv. 2020 Aug 25;10(52):31385-31399. doi: 10.1039/d0ra03167d. eCollection 2020 Aug 21.
4
Angiotensin-converting enzyme 2 and transmembrane protease serine 2 in female and male patients with end-stage kidney disease.血管紧张素转换酶 2 和跨膜丝氨酸蛋白酶 2 在女性和男性终末期肾病患者中的表达。
Eur J Clin Invest. 2022 Aug;52(8):e13786. doi: 10.1111/eci.13786. Epub 2022 Apr 9.
5
Association between COVID-19 Diagnosis and Coronary Artery Thrombosis: A Narrative Review.2019冠状病毒病诊断与冠状动脉血栓形成之间的关联：一项叙述性综述
Biomedicines. 2022 Mar 18;10(3):702. doi: 10.3390/biomedicines10030702.
6
Molecular Insights of SARS-CoV-2 Antivirals Administration: A Balance between Safety Profiles and Impact on Cardiovascular Phenotypes.新型冠状病毒2型抗病毒药物给药的分子见解：安全性与对心血管表型影响之间的平衡
Biomedicines. 2022 Feb 14;10(2):437. doi: 10.3390/biomedicines10020437.
7
COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A review.新型冠状病毒肺炎疫苗诱导的免疫性血栓性血小板减少症：综述
Ann Thorac Med. 2022 Jan-Mar;17(1):1-13. doi: 10.4103/atm.atm_404_21. Epub 2022 Jan 14.
8
Interactions of renin-angiotensin system and COVID-19: the importance of daily rhythms in ACE2, ADAM17 and TMPRSS2 expression.肾素-血管紧张素系统与 COVID-19 的相互作用：ACE2、ADAM17 和 TMPRSS2 表达的昼夜节律的重要性。
Physiol Res. 2021 Dec 16;70(S2):S177-S194. doi: 10.33549/physiolres.934754.
9
Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin-angiotensin-aldosterone system (RAAS) dysregulation.心血管疾病患者 COVID-19 并发症增加：肾素-血管紧张素-醛固酮系统（RAAS）失调的作用。
Chem Biol Interact. 2022 Jan 5;351:109738. doi: 10.1016/j.cbi.2021.109738. Epub 2021 Nov 3.
10
Venous thromboembolism in patients with COVID-19 infection: risk factors, prevention, and management.新型冠状病毒肺炎感染患者的静脉血栓栓塞症：危险因素、预防和管理。
Semin Vasc Surg. 2021 Sep;34(3):101-116. doi: 10.1053/j.semvascsurg.2021.06.002. Epub 2021 Aug 4.
人类心脏中的 ACE2 表达表明了 SARS-CoV-2 感染患者心脏损伤的新潜在机制。
Cardiovasc Res. 2020 May 1;116(6):1097-1100. doi: 10.1093/cvr/cvaa078.
4
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.新冠肺炎住院患者中心脏损伤与死亡的相关性研究：中国武汉。
JAMA Cardiol. 2020 Jul 1;5(7):802-810. doi: 10.1001/jamacardio.2020.0950.
5
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State.华盛顿州 21 例 COVID-19 危重症患者的特征和结局。
JAMA. 2020 Apr 28;323(16):1612-1614. doi: 10.1001/jama.2020.4326.
6
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
7
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?高血压和糖尿病患者感染新型冠状病毒肺炎（COVID-19）的风险会增加吗？
Lancet Respir Med. 2020 Apr;8(4):e21. doi: 10.1016/S2213-2600(20)30116-8. Epub 2020 Mar 11.
8
Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?可溶性血管紧张素转化酶 2：冠状病毒感染治疗的潜在方法？
Clin Sci (Lond). 2020 Mar 13;134(5):543-545. doi: 10.1042/CS20200163.
9
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）进入细胞依赖于 ACE2 和 TMPRSS2，可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
10
Preventing a covid-19 pandemic.预防新冠疫情。
BMJ. 2020 Feb 28;368:m810. doi: 10.1136/bmj.m810.